{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:17:11Z","timestamp":1740107831804,"version":"3.37.3"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0108636","JP24fk0108636"],"award-info":[{"award-number":["JP23fk0108636","JP24fk0108636"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jiac.2024.08.024","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T04:34:14Z","timestamp":1724992454000},"page":"102509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection"],"prefix":"10.1016","volume":"31","author":[{"given":"Shunsuke","family":"Yazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Fukuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rie","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masae","family":"Itamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriaki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5513-5661","authenticated-orcid":false,"given":"Hiroyasu","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6309-277X","authenticated-orcid":false,"given":"Hideki","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.08.024_bib1","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of sars-cov-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2024.08.024_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"Sars-cov-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jiac.2024.08.024_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijid.2023.09.010","article-title":"Virus evolution and reduced viral viability during treatment of persistent covid-19 omicron ba.5 infection in an immunocompromised host","volume":"136","author":"Kaya","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.024_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2072455","article-title":"Novel super-neutralizing antibody ut28k is capable of protecting against infection from a wide variety of sars-cov-2 variants","volume":"14","author":"Ozawa","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.jiac.2024.08.024_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/JS9.0000000000000219","volume":"109","author":"Chakraborty","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.jiac.2024.08.024_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02473-21","article-title":"A combination of receptor-binding domain and n-terminal domain neutralizing antibodies limits the generation of sars-cov-2 spike neutralization-escape mutants","volume":"12","author":"Haslwanter","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.jiac.2024.08.024_bib7","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1038\/s41467-023-38867-x","article-title":"Sequential intrahost evolution and onward transmission of sars-cov-2 variants","volume":"14","author":"Gonzalez-Reiche","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2024.08.024_bib8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping neutralizing and immunodominant sites on the sars-cov-2 spike receptor-binding domain by structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jiac.2024.08.024_bib9","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.cell.2021.05.032","article-title":"An infectivity-enhancing site on the sars-cov-2 spike protein targeted by antibodies","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jiac.2024.08.024_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13914","article-title":"De novo emergence of sars-cov-2 spike mutations in immunosuppressed patients","volume":"24","author":"Simons","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jiac.2024.08.024_bib11","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.cell.2021.03.027","article-title":"Sars-cov-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms","volume":"184","author":"Clark","year":"2021","journal-title":"Cell"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24002411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T11:47:14Z","timestamp":1738928834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24002411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1341321X24002411"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.024","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of virus and antibody response in an immunocompromised patient with persistent SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102509"}}